Skip to main content Skip to secondary navigation

Enroll Yourself in Autumn IntroSems with Space Available

IntroSems with Space Available open for self-enrollment in SimpleEnroll the afternoon of September 18th when new students can start to enroll in their other fall classes. Frosh, Sophomores, and New Transfers have priority for open spaces; upper class students should check back after Sept. 18.
 

All applicants who were admitted to Autumn IntroSems were enrolled by Sept. 16th provided they had space for the seminar units on their study lists and no enrollment holds (excluding New Student Advisement hold).

Main content start

GENE 104Q: Law and the Biosciences

Application Deadline: August 26. This course is expected to experience high student demand.
Rainbow Babies by k8tty, cropped. From Deviant Art. Creative Commons Attribution 3.0 License.

Frosh should not apply for Sophomore WRITE-2 IntroSems like this because Sophomores receive priority for all seats in this class.

Sophomores & eligible New Transfer Students, please note: If Autumn is your PWR2 quarter, you still must submit your 7 PWR2 preferences at vcapwr.stanford.edu; applying for this seminar in the IntroSems' VCA does not negate that step. If you are admitted for this WRITE-2 seminar, the course will be added to your study list. This IntroSem will be considered your first choice PWR2 and with admission to the seminar, you will lose all other PWR2 section preferences.

This course is expected to experience high student demand. Sophomores and new transfers who decide to rank a high-demand WRITE-2 seminar when making their three selections for priority enrollment are encouraged to apply for a second and third choice seminar for the quarter. You are also encouraged to write an additional statement for your lower ranked selection(s) so those faculty learn about your interest.


Course Description

Should parents be allowed to choose the genetic traits of their children? How should courts use neuroimaging to read the minds of witnesses? How will cheap and common whole genome sequencing change medicine and society? What will happen if we can make eggs and sperm from skin cells, using induced pluripotent stem cell technology? 

This seminar will examine legal, social, and ethical issues arising from advances in the biosciences. Much of the course will focus on human genetics, but we will also look at advances in assisted reproduction and in neuroscience. Specific topics may (or may not) include forensic use of DNA, genetic testing, genetic discrimination, eugenics, cloning, pre-implantation genetic diagnosis, neuroscientific methods of lie detection and genetic or neuroscience enhancement, and other issues that seem interesting this autumn. Students will be required to make two short oral presentations, write a research paper, and deliver an oral presentation of their paper's conclusions. Students will be expected to attend every session as our joint discussion is the class’s most important aspect.

This course fulfills the second-level Writing and Rhetoric Requirement (WRITE 2) and emphasizes oral presentation.


Meet the Instructor: Henry T. (Hank) Greely

Henry T. (Hank) Greely

"I am a professor of law and a professor, by courtesy, of genetics. I specialize in legal and social implications of advances in the biosciences. I’ve written on genetics, human cloning, stem cell research, and neuroscience, as well as more general issues of the ethics of human subjects research and of human biological enhancement. I direct the Stanford Center for Law and the Biosciences and chair the steering committee of Stanford's Center for Biomedical Ethics. I received my B.A. in political science at Stanford (‘74) and my J.D. from Yale. I was a law clerk for Judge John Minor Wisdom on the United States Court of Appeals and for Justice Potter Stewart of the United States Supreme Court. After working during the Carter administration in the Defense and Energy Departments, I was in private law practice as a litigator in Los Angeles for four years. I joined the Law School faculty in 1985."

More News